Company intelligence
CREATE Medicines
Biotechnology
Cambridge, US
46 employees
2 public signals
About CREATE Medicines
CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming. Its proprietary mRNA-LNP platform directly programs immune cells inside the body to deliver scalable, repeat-dose, off-the-shelf immunotherapies. With proven human validation and next-generation RNA technology, CREATE is advancing a pipeline of in vivo CAR therapies to transform outcomes in cancer, autoimmunity, and fibrosis.
Verified activity
Signals from CREATE Medicines
2 published signals